Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 3
2001 4
2002 2
2003 2
2004 3
2005 2
2006 2
2007 2
2008 3
2009 8
2010 8
2011 3
2012 7
2013 4
2014 5
2015 9
2016 6
2017 13
2018 7
2019 10
2020 2
2021 3
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33067337

98 results
Results by year
Filters applied: . Clear all
Page 1
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
Yoshinaga K, Oriuchi N, Wakabayashi H, Tomiyama Y, Jinguji M, Higuchi T, Kayano D, Fukuoka M, Inaki A, Toratani A, Okamoto S, Shiga T, Ito YM, Nakajo M, Nakajo M, Kinuya S; Drafting Committee for Guidelines on Internal Radiotherapy with ¹³¹I-MIBG; Japanese Society of Nuclear Medicine in Oncology and Imunology; Japanese Society of Nuclear Medicine. Yoshinaga K, et al. Endocr J. 2014;61(12):1171-80. doi: 10.1507/endocrj.EJ14-0211. Epub 2014 Sep 11. Endocr J. 2014. PMID: 25214026 Free article.
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.
Delpassand ES, Samarghandi A, Mourtada JS, Zamanian S, Espenan GD, Sharif R, Mackenzie S, Kosari K, Barakat O, Naqvi S, Seng JE, Anthony L. Delpassand ES, et al. Theranostics. 2012;2(5):472-80. doi: 10.7150/thno.3739. Epub 2012 May 11. Theranostics. 2012. PMID: 22737186 Free PMC article.
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P, Ranade R, Ostwal V, Shrikhande SV, Goel M, Basu S. Thapa P, et al. Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547. Nucl Med Commun. 2016. PMID: 27243215
Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.
Pandit-Taskar N, Zanzonico P, Staton KD, Carrasquillo JA, Reidy-Lagunes D, Lyashchenko S, Burnazi E, Zhang H, Lewis JS, Blasberg R, Larson SM, Weber WA, Modak S. Pandit-Taskar N, et al. J Nucl Med. 2018 Jan;59(1):147-153. doi: 10.2967/jnumed.117.193169. Epub 2017 Jul 13. J Nucl Med. 2018. PMID: 28705916 Free PMC article. Clinical Trial.
Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma.
Jha A, de Luna K, Balili CA, Millo C, Paraiso CA, Ling A, Gonzales MK, Viana B, Alrezk R, Adams KT, Tena I, Chen A, Neuzil J, Raygada M, Kebebew E, Taieb D, O'Dorisio MS, O'Dorisio T, Civelek AC, Stratakis CA, Mercado-Asis L, Pacak K. Jha A, et al. Front Oncol. 2019 Feb 22;9:53. doi: 10.3389/fonc.2019.00053. eCollection 2019. Front Oncol. 2019. PMID: 30854332 Free PMC article.
98 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page